Vosevi Tablet, Film Coated
Product Images NDC 61958-2401

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vosevi (NDC 61958-2401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Vosevi 01)

FDA Label Image

Chemical Structure (Vosevi 02)

FDA Label Image

Chemical Structure (Vosevi 03)

FDA Label Image

Chemical Structure (Vosevi 04)

FDA Label Image

Principal Display Panel (28 Tablet Bottle Label)

This text describes the constituents of Vosevi tablets, with each tablet comprising of 400mg sofosbuvir, 100mg velpatasvir, and 100mg voxilaprev, along with storage instructions and directions for dosage and administration. The tablets are manufactured by Gilead Sciences, Inc. in Ireland and come in an original container. It is recommended to check the package insert for further information about the medication. The text also mentions a warning to not take it with certain other medications, and not to cover the alert box on the packaging with a pharmacy label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.